Defeat Duchenne Canada launches 2023 Research Grant Program
Defeat Duchenne Canada (DDC) is the country’s largest charitable source of investment in cutting-edge Duchenne muscular dystrophy research. DDC have funded $16 million into the most promising international research focussed on improving outcomes for all individuals with this progressive disease.
DDC invites all investigators working on translational or clinical Duchenne research to apply to their 2023 Research Grant Program!
Funding Criteria
Read the full funding criteria to learn more about the grant program.
Upcoming Deadlines
The deadline to submit a letter of intent is April 21st, 2023.
Submit a letter of intent through the DDC web portal.
Read next...
Announcing the 2026 NMD4C Award Recipients
We are excited to announce the recipients of the 2026 NMD4C Awards, recognizing excellence, leadership, and impact across Canada’s neuromuscular research community. In this fourth cycle, the program introduces two new award categories, and expand on our ability to celebrate the work of contributions of trainees and patient partners who strengthen our national network.
Expanding Our Impact: NMD4C BSTC Launches New Subcommittees and Welcomes New Members
We are so excited to introduce the new members of the NMD4C Basic Science Trainee Committee! This enthusiastic group of researchers from across the country is stepping up to contribute to some of our most important initiatives for trainees.
